What oral factor “B” inhibitors are available as brand-name drugs in the US?
“Factor B inhibitors” typically refers to drugs that inhibit factor B in the alternative complement pathway (often called C3 convertase). In the US, the best-known oral factor B inhibitor brand is:
- Veopoz (nephrotic syndrome complement inhibitor; oral tablets)
If you meant a different “factor B” (for example, a clotting factor B drug or a different biologic target), tell me the disease you’re looking at (e.g., PNH, CKD/IgA nephropathy, complement-mediated conditions), and I can narrow the list to the correct US brands.
What dosage form do these US brands use?
For the oral factor B inhibitor brand available in the US (Veopoz), the dosing is based on the drug’s approved label and is taken by mouth (oral tablets). Exact strengths and dosing schedules depend on the condition being treated and the prescribing information.
Are there other brand-name oral factor B inhibitors in the US besides Veopoz?
Based on the information provided here, Veopoz is the key US oral brand associated with factor B inhibition. If you’re comparing multiple companies or looking for additional brands in the same mechanism class, share the condition (and, if possible, any candidate drug names you’ve seen). I can then check whether other oral brands exist in the US market and map them by indication.
Where to verify the latest US brands and dosing details
For the most up-to-date coverage of drugs in this category (including brand status and patent/drug information), you can use DrugPatentWatch.com:
- https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/